RTTNews | Jun 22, 2021 10:36AM EDT

10:35 Tuesday, June 22, 2021 (RTTNews.com) - Adial Pharmaceuticals, Inc. (ADIL) shares are gaining more than 16 percent on Tuesday morning trade as the company announced plans to enter the genetic testing market after it received a Notice of Allowance from the U.S. Patent and Trademark Office for use of its product AD04 for the treatment of Alcohol Use Disorder or AUD and Opioid Use Disorder or OUD. The company said genetic evaluation of patients can be used to identify individuals that may benefit from AD04.

Currently, shares are at $3.35, up 16.72 percent from the previous close of $2.87 on a volume of 20,747,601. For the 52-week period, the shares have traded in a range of $1.14-$4.00 on average volume of 226,153.

Read the original article on RTTNews ( https://www.rttnews.com/3204103/adial-pharma-up-16-on-plan-to-enter-genetic-testing-market.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved